Cargando…

Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) represents a global health challenge, with limited therapies proven to enhance patient outcomes. This makes the elucidation of disease mechanisms and the identification of novel potential therapeutic targets a priority. Here, we performed RNA se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inácio, José M., Cristo, Fernando, Pinheiro, Miguel, Vasques-Nóvoa, Francisco, Saraiva, Francisca, Nunes, Mafalda M., Rosas, Graça, Reis, Andreia, Coimbra, Rita, Oliveira, José Luís, Moura, Gabriela, Leite-Moreira, Adelino, Belo, José António
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452106/ https://www.ncbi.nlm.nih.gov/pubmed/37626628 http://dx.doi.org/10.3390/biomedicines11082131

Ejemplares similares

Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction
por: Sebastião, Maria J., et al.
Publicado: (2022)

Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update
por: Vaz-Salvador, Pedro, et al.
Publicado: (2022)

Gene-Edited Human-Induced Pluripotent Stem Cell Lines to Elucidate DAND5 Function throughout Cardiac Differentiation
por: Inácio, José M., et al.
Publicado: (2023)

Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial
por: Neves, João Sérgio, et al.
Publicado: (2022)

Body mass index effect on long-term survival after coronary artery bypass surgery: a competing risk analysis
por: Abreu, Armando, et al.
Publicado: (2023)

Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
por: Neves, João Sérgio, et al.
Publicado: (2020)

DAND5 Inactivation Enhances Cardiac Differentiation in Mouse Embryonic Stem Cells
por: Inácio, José Manuel, et al.
Publicado: (2021)

Functional study of DAND5 variant in patients with Congenital Heart Disease and laterality defects
por: Cristo, Fernando, et al.
Publicado: (2017)

Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk‐related rat model of heart failure with preserved ejection fraction
por: Miranda‐Silva, Daniela, et al.
Publicado: (2019)

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
por: Antonelli, Lucas, et al.
Publicado: (2015)

Exercise preconditioning prevents left ventricular dysfunction and remodeling in monocrotaline-induced pulmonary hypertension
por: Schmidt, Cristine, et al.
Publicado: (2020)

Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction
por: van Heerebeek, Loek, et al.
Publicado: (2013)

Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial
por: Ferreira, João Pedro, et al.
Publicado: (2021)

Assessing the influence of perfusion on cardiac microtissue maturation: A heart‐on‐chip platform embedding peristaltic pump capabilities
por: Cruz‐Moreira, Daniela, et al.
Publicado: (2021)

Myocardial oedema: pathophysiological basis and implications for the failing heart
por: Vasques‐Nóvoa, Francisco, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Yoga and breathing technique training in patients with heart failure and preserved ejection fraction: study protocol for a randomized clinical trial
por: Lopes, Carla Pinheiro, et al.
Publicado: (2018)

OR19-2 Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) with Low and High Dose of Triiodothyronine: an Animal Model of Metabolic Syndrome with HFpEF
por: Almeida-Coelho, João, et al.
Publicado: (2022)

Assessing Strategies for Heart Failure with Preserved Ejection Fraction at the Outpatient Clinic
por: Jorge, Antonio José Lagoeiro, et al.
Publicado: (2014)

Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction: State of the Art and Prospects for the Future
por: Fernandes, Sara Lopes, et al.
Publicado: (2020)

Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction
por: López‐Vilella, Raquel, et al.
Publicado: (2021)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Prevalence of peripheral arterial disease in patients with heart failure with preserved ejection fraction
por: da Cunha, Giuliano Reolon, et al.
Publicado: (2019)

Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2017)

The impact of heart failure therapy in patients with mildly reduced ejection fraction: a network meta‐analysis
por: Leite, Marta, et al.
Publicado: (2023)

Vibrational spectroscopy identifies myocardial chemical modifications in heart failure with preserved ejection fraction
por: Pioppi, Leonardo, et al.
Publicado: (2023)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2018)

Modelling the complexity of heart failure with preserved ejection fraction
por: O’Gallagher, Kevin, et al.
Publicado: (2018)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Heart Failure With Preserved Ejection Fraction: An Opportunity for Reflection
por: Gupta, Deepak K.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7ag776megqnfde2hn5d0p86paq